Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1806 | Etoposide | Topo II | Chemotherapy | 0.096233 | -0.5629 | 0.6490 | 0.2019 | 0.9767 | 0.2057 | 0.99535 |
SK-BR-3 | Etoposide | Topo II | Chemotherapy | 0.39826 | -0.3169 | 0.4040 | 0.1186 | 1.5701 | 0.532 | 0.99524 |
PDX1328 | Topotecan | Topo I | Chemotherapy | 0.0059222 | -0.9128 | 1.0720 | 0.1509 | 0.4616 | 0.063175 | 0.94441 |
HCC1419 | Doxorubicin | Chemo | Chemotherapy | 0.025082 | -0.4663 | 0.5904 | 0.0473 | 0.5199 | 0.10425 | 0.94593 |
SK-BR-3 | Topotecan | Topo I | Chemotherapy | 0.016549 | -0.2711 | 0.7941 | 0.1919 | 1.9350 | 0.01923 | 0.98214 |
SK-BR-3 | Taxol | Chemo | Chemotherapy | 0.0019068 | -0.3401 | 0.8905 | 0.3665 | 2.3888 | 0.0023578 | 0.96349 |
PDX1328 | Doxorubicin | Chemo | Chemotherapy | 0.013267 | -0.7789 | 0.8023 | 0.1468 | 1.4934 | 0.021574 | 0.96338 |
SK-BR-3 | Doxorubicin | Chemo | Chemotherapy | 0.0067336 | -0.6156 | 0.9421 | 0.3142 | 1.5278 | 0.010801 | 0.99572 |
SK-BR-3 | Cisplatin | Chemo | Chemotherapy | 5.1075 | 0.2490 | 0.0978 | 0.0114 | 1.4151 | 5.7965 | 0.99044 |
Hs 578T | Etoposide | Topo II | Chemotherapy | 0.41322 | -0.1361 | 0.3770 | 0.1666 | 2.0332 | 0.46109 | 0.99901 |
PDX1328 | Etoposide | Topo II | Chemotherapy | 0.80493 | -0.2805 | 0.3502 | 0.0172 | 1.4732 | 1.1571 | 0.98432 |
Hs 578T | Topotecan | Topo I | Chemotherapy | 0.0049855 | -0.4488 | 1.0175 | 0.4717 | 1.1814 | 0.0076404 | 0.9429 |
HCC1806 | Taxol | Chemo | Chemotherapy | 0.0014225 | -0.2113 | 0.8398 | 0.3493 | 2.1569 | 0.0016621 | 0.96243 |
PDX1258 | Etoposide | Topo II | Chemotherapy | 0.31701 | -0.1807 | 0.3942 | 0.1360 | 1.0906 | 0.41876 | 0.99346 |
Hs 578T | Taxol | Chemo | Chemotherapy | 0.0010154 | -0.3752 | 0.9535 | 0.4788 | 1.2811 | 0.0015458 | 0.95438 |
MDA-MB-453 | Taxol | Chemo | Chemotherapy | 0.002374 | 0.0356 | 0.6674 | 0.1683 | 1.2620 | 0.0023576 | 0.81734 |
HCC1937 | Taxol | Chemo | Chemotherapy | 0.0024514 | 0.0104 | 0.6576 | 0.2104 | 2.2541 | 0.0024561 | 0.99541 |
MDA-MB-453 | Topotecan | Topo I | Chemotherapy | 0.0066897 | -0.5289 | 0.9258 | 0.1604 | 1.0131 | 0.010358 | 0.92364 |
Hs 578T | Doxorubicin | Chemo | Chemotherapy | 0.0041078 | -0.3466 | 0.8007 | 0.2450 | 1.2269 | 0.0052684 | 0.96807 |
PDX1328 | Cisplatin | Chemo | Chemotherapy | 0.77968 | -0.4217 | 0.3154 | 0.0259 | 1.3251 | 1.2886 | 0.9879 |
Hs 578T | Cisplatin | Chemo | Chemotherapy | 1.5413 | 0.0125 | 0.2347 | 0.0930 | 1.4392 | 1.6968 | 0.99339 |
MDA-MB-453 | Doxorubicin | Chemo | Chemotherapy | 0.0058313 | -0.3476 | 0.7915 | 0.1805 | 1.7510 | 0.0071438 | 0.98132 |
MDA-MB-453 | Etoposide | Topo II | Chemotherapy | 0.38265 | -0.0601 | 0.3658 | 0.0418 | 1.5864 | 0.41689 | 0.99692 |
HCC1937 | Topotecan | Topo I | Chemotherapy | 0.0155 | -0.4282 | 0.8369 | 0.2949 | 0.6712 | 0.03544 | 0.94323 |
PDX1258 | Taxol | Chemo | Chemotherapy | 0.0021522 | -0.0818 | 0.6797 | 0.2357 | 1.2501 | 0.0022935 | 0.98829 |